MedTrace Logo

Impact of New Hormone Replacement Therapy After Menopause on Heart Health in Women

NCT07394049 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2725

Last updated 2026-02-10

No results posted yet for this study

Summary

This prospective registry study investigates the impact of new hormone replacement therapy (HRT) delivery methods, such as creams, gels, and sprays, on cardiovascular risk in postmenopausal women. Menopause-related estrogen deficiency leads to metabolic and vascular changes that increase atherosclerosis and cardiovascular events. This study hypothesizes that new HRT forms may reduce cardiovascular risk in high-risk women."

Conditions

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    lead OTHER

Principal Investigators

  • Malte Kelm, MD · Division of Cardiology, Pulmonary Disease and Vascular Medicine at University Hospital Duesseldorf

  • Lisa Dannenberg, MD · Division of Cardiology, Pulmonary Disease and Vascular Medicine at University Hospital Duesseldorf

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2035-03-31
Completion
2035-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07394049 on ClinicalTrials.gov